Restless Legs Syndrome Trial, Recruiting (NCT06918847)

Restless Legs Syndrome Trial, Recruiting NCT06918847 Sponsor: Dow University of Health Sciences Condition: Restless Legs Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT06918847 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Restless Legs Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with knee osteoarthritis (joint wear and tear) that has been graded as moderate to severe (grade 2, 3, or 4) using a standard medical grading system
You have osteoarthritis in one or both knees
You are between 40 and 70 years old
You meet the recognized diagnostic criteria for Restless Legs Syndrome (an uncomfortable urge to move the legs, especially at rest) as defined by an international study group (confirm with trial site)

Who may not be able to join:

You have been diagnosed with cognitive dysfunction (problems with memory, thinking, or concentration)
You have rheumatoid arthritis (an autoimmune condition causing joint inflammation)
You have a neurological disorder (a condition affecting the brain, spinal cord, or nerves)
You have certain other health conditions, including heart or blood vessel disease, severe mental health illness, or if you are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +923362196775

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06918847

Sponsor: Dow University of Health Sciences

Phase: Not Applicable

Status: Recruiting

Condition: Restless Legs Syndrome

Trial contact: +923362196775

More information: https://clinicaltrials.gov/study/NCT06918847

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with knee osteoarthritis (joint wear and tear) that has been graded as moderate to severe (grade 2, 3, or 4) using a standard medical grading system
You have osteoarthritis in one or both knees
You are between 40 and 70 years old
You meet the recognized diagnostic criteria for Restless Legs Syndrome (an uncomfortable urge to move the legs, especially at rest) as defined by an international study group (confirm with trial site)

Who may not be able to join:

You have been diagnosed with cognitive dysfunction (problems with memory, thinking, or concentration)
You have rheumatoid arthritis (an autoimmune condition causing joint inflammation)
You have a neurological disorder (a condition affecting the brain, spinal cord, or nerves)
You have certain other health conditions, including heart or blood vessel disease, severe mental health illness, or if you are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Dow University of Health Sciences

Registry

ClinicalTrials.gov

Start date

5 May 2025

Est. completion

1 November 2025

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Restless leg syndrome quality of life Questionnaire; International restless leg syndrome study group rating scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov